Ventricular fibrillation in an ambulatory patient supported by a left ventricular assist device: highlighting the ICD controversy
Related Experiment Video
Updated: May 24, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Barry A Boilson1, Lucian A Durham, Soon J Park
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA. boilson.barry@mayo.edu
Abstract:
Left ventricular assist devices (LVADs) provide an effective means of managing advanced pump failure as a means of bridging to cardiac transplantation or as permanent therapy. Although ventricular arrhythmias remain common post-LVAD implantation, such therapy may allow malignant arrhythmias to be tolerated hemodynamically. This report describes the clinical findings in a patient who had likely been in a ventricular tachyarrhythmia for several days and presented in ventricular fibrillation, ambulatory, and mentating normally. This report, with previous similar reports, is additive to the body of evidence that LVADs alter the physiologic impact of ventricular arrhythmias in advanced heart failure and highlights the need for thoughtful programming of implantable cardioverter defibrillator therapies in these patients.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
